Additional Low Voltage Area Ablation in Older Patients With Paroxysmal Atrial Fibrillation

NCT03462628 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 438

Last updated 2022-05-04

No results posted yet for this study

Summary

The primary objective of this investigation is to compare the efficacy of two different AF ablation strategies in older patients with paroxysmal AF: Pulmonary vein isolation alone versus additional low-voltage substrate modification during sinus rhythm

Conditions

  • Paroxysmal Atrial Fibrillation

Interventions

PROCEDURE

CPVI plus low-voltage substrate modification

CPVI plus low-voltage substrate modification in the left atrium during SR

PROCEDURE

CPVI alone

circumferential pulmonary vein isolation

Sponsors & Collaborators

  • The Affiliated Hospital of Xuzhou Medical University

    collaborator OTHER
  • First Affiliated Hospital of Wannan Medical College

    collaborator OTHER
  • Second Affiliated Hospital of Nantong University

    collaborator OTHER
  • Zhongda Hospital

    collaborator OTHER
  • The Third Affiliated Hospital of Soochow University

    collaborator OTHER
  • The Second Hospital of Hebei Medical University

    collaborator OTHER
  • The First Affiliated Hospital of Soochow University

    collaborator OTHER
  • Xuzhou Central Hospital, the Affiliated Xuzhou Hospital of Medical College of Southeast University

    collaborator UNKNOWN
  • Air Force Military Medical University, China

    collaborator OTHER
  • The First Affiliated Hospital with Nanjing Medical University

    lead OTHER

Principal Investigators

  • Minglong Chen · The First Affiliated Hospital with Nanjing Medical University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-04-24
Primary Completion
2020-08-03
Completion
2021-08-17

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03462628 on ClinicalTrials.gov